Heparin Versus Bivalirudin Monotherapy in the Setting of Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction.

Faulkenberg, Kathleen D; Beavers, Janna C; Finks, Shannon W

Faulkenberg, Kathleen D; Beavers, Janna C; Finks, Shannon W.

Affiliation

Faulkenberg KD; Cleveland Clinic, Cleveland, OH, USA faulkek@ccf.org.
Beavers JC; WakeMed Health and Hospitals, Raleigh, NC, USA.
Finks SW; University of Tennessee College of Pharmacy, Memphis, TN, USA.

Ann Pharmacother ; 50(2): 141-51, 2016 Feb.

Article in En | MEDLINE | ID: mdl-26681442

Subject(s)

Heparin/therapeutic use; Peptide Fragments/therapeutic use; Percutaneous Coronary Intervention; Anticoagulants/therapeutic use; Antithrombins/therapeutic use; Hemorrhage/chemically induced; Heparin/adverse effects; Hirudins; Humans; Myocardial Infarction/therapy; Platelet Aggregation Inhibitors/therapeutic use; Randomized Controlled Trials as Topic; Recombinant Proteins/therapeutic use

Key words

ST-segment myocardial infarction; bivalirudin; heparin; primary percutaneous coronary intervention

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Peptide Fragments / Heparin / Percutaneous Coronary Intervention Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google